Influence of age on the pharmacokinetics of alfentanil. Gender dependence
- PMID: 2268988
- DOI: 10.2165/00003088-199019050-00005
Influence of age on the pharmacokinetics of alfentanil. Gender dependence
Abstract
Studies on the effects of age on the pharmacokinetics of alfentanil are inconclusive. A possible factor in explaining the differences between various studies could be the effect of gender. The authors studied the effects of age on the pharmacokinetics of alfentanil in female (n = 21) and male (n = 15) patients undergoing lower abdominal surgery under nitrous oxide alfentanil anaesthesia. There was a significant negative correlation (r = -0.79, p less than 0.001) between plasma alfentanil clearance (CL) and age in women (less than 50y, median CL 24.84 L/h; greater than 50y, median CL 14.52 L/h), but not in men (less than 50y, median CL 19.44 L/h; greater than 50y, median CL 16.2 L/h). The conclusion is drawn that the effects of age on the pharmacokinetics of alfentanil are gender-dependent.
Comment in
-
Sex, age and alfentanil pharmacokinetics.Clin Pharmacokinet. 1991 Jul;21(1):81-2. doi: 10.2165/00003088-199121010-00006. Clin Pharmacokinet. 1991. PMID: 1914343 No abstract available.
Similar articles
-
Pharmacokinetics of alfentanil administered at a variable rate during three types of surgery.Eur J Anaesthesiol. 1993 Jul;10(4):241-51. Eur J Anaesthesiol. 1993. PMID: 8330593
-
Alfentanil pharmacokinetics in patients undergoing abdominal aortic surgery.Can J Anaesth. 1991 Jan;38(1):61-7. doi: 10.1007/BF03009165. Can J Anaesth. 1991. PMID: 1989741
-
[Analgo-sedation in intensive care: a quantitative, EEG-based trial with propofol 1% and 2%].Anaesthesist. 1999 Nov;48(11):794-801. doi: 10.1007/s001010050787. Anaesthesist. 1999. PMID: 10631438 Clinical Trial. German.
-
Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients.Anesthesiology. 1987 Jan;66(1):3-12. Anesthesiology. 1987. PMID: 3099604
-
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.Clin Pharmacokinet. 1996 Oct;31(4):275-92. doi: 10.2165/00003088-199631040-00004. Clin Pharmacokinet. 1996. PMID: 8896944 Review.
Cited by
-
Age-related changes in hepatic function. Implications for drug therapy.Drugs Aging. 1992 May-Jun;2(3):243-55. doi: 10.2165/00002512-199202030-00007. Drugs Aging. 1992. PMID: 1606355 Review.
-
Do women need a change in dose of prescription drugs with onset of menopause? Time to find out.BMC Med. 2025 Jul 7;23(1):411. doi: 10.1186/s12916-025-04253-1. BMC Med. 2025. PMID: 40624672 Free PMC article. No abstract available.
-
Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?Clin Pharmacokinet. 2006;45(1):1-11. doi: 10.2165/00003088-200645010-00001. Clin Pharmacokinet. 2006. PMID: 16430308
-
Sex, age and alfentanil pharmacokinetics.Clin Pharmacokinet. 1991 Jul;21(1):81-2. doi: 10.2165/00003088-199121010-00006. Clin Pharmacokinet. 1991. PMID: 1914343 No abstract available.
-
The influence of age and sex on the clearance of cytochrome P450 3A substrates.Clin Pharmacokinet. 2005;44(1):33-60. doi: 10.2165/00003088-200544010-00002. Clin Pharmacokinet. 2005. PMID: 15634031 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical